Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Older age, being male, and Asian ethnicity led to worse COVID-19 outcomes, with many experiencing long-term symptoms.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Anabolic steroid users may face higher risk of severe COVID-19.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

There's no significant genetic link between male pattern baldness and COVID-19.

Male hormones may increase the severity and death rates of COVID-19.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

PRP therapy can effectively treat hair loss after COVID-19 vaccination.

Most people in South India lack knowledge about managing COVID-19 at home.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Public interest in hair loss increased during the COVID-19 pandemic.

A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.

A combination of arginine silicate complex and magnesium biotinate improves hair and nail growth in rats.

S-equol supplements significantly reduced menopausal symptoms in most women.